論文一覧｜長崎大学熱帯医学研究所ウイルス学分野

学会発表

2021-09-29

Sandra Kendra Raini

The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection.

学会発表

2021-09-29

Elizabeth Ajema Chebichi Luvai,

Evidence of Chikungunya virus seroprevalence in Myanmar among Dengue suspected patients and healthy volunteers in the years 2013, 2015 and 2018.

学会発表

2021-09-11

Jean Claude Balingit

A simple and high-throughput alternative virus assay in the serologic diagnosis of mosquito-borne flavivirus infections.

学会発表

2021-09-11

Mizuki Fukuta

Discrepancies in infectivity of flavivirus and SARS-CoV-2 clinical samples: An Improved assay for infectious virus shedding and viremia assessment.

学会発表

2021-09-11

Mya Myat Ngwe Tun

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar.

論文発表

2021-09-03

Toru Takenaga, Zihan Zhang, Yukiko Muramoto, et al.

CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.

その他

2021-08-01

Yuki Takamatsu

Yuki Takamatsu has been accepted for AMED 2021 Establishment of the research base for BSL-4 facility and capacity building of researchers on category I (highly pathogenic) pathogen

その他

2021-07-21

Yuki Takamatsu

Yuki Takamatsu has been accepted by the "Takeda Science Foundation Medical Research Grant"

学会発表

2021-05-24

Jean Claude Balingit

The Impact of DENV-1 Genotypes on the Immune Response of Natural Homotypic Infections.

論文発表

2021-04-16

Shiori Sano, Shutetsu Fukushi, Souichi Yamada, et al.

Paper

The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection.

Evidence of Chikungunya virus seroprevalence in Myanmar among Dengue suspected patients and healthy volunteers in the years 2013, 2015 and 2018.

A simple and high-throughput alternative virus assay in the serologic diagnosis of mosquito-borne flavivirus infections.

Discrepancies in infectivity of flavivirus and SARS-CoV-2 clinical samples: An Improved assay for infectious virus shedding and viremia assessment.

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar.

CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.

Yuki Takamatsu has been accepted for AMED 2021 Establishment of the research base for BSL-4 facility and capacity building of researchers on category I (highly pathogenic) pathogen

Yuki Takamatsu has been accepted by the "Takeda Science Foundation Medical Research Grant"

The Impact of DENV-1 Genotypes on the Immune Response of Natural Homotypic Infections.

Development of an RT-LAMP Assay for the Rapid Detection of SFTS Virus.

Paper

The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection.

Evidence of Chikungunya virus seroprevalence in Myanmar among Dengue suspected patients and healthy volunteers in the years 2013, 2015 and 2018.

A simple and high-throughput alternative virus assay in the serologic diagnosis of mosquito-borne flavivirus infections.

Discrepancies in infectivity of flavivirus and SARS-CoV-2 clinical samples: An Improved assay for infectious virus shedding and viremia assessment.

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar.

CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.

Yuki Takamatsu has been accepted for AMED 2021 Establishment of the research base for BSL-4 facility and capacity building of researchers on category I (highly pathogenic) pathogen

Yuki Takamatsu has been accepted by the &quot;Takeda Science Foundation Medical Research Grant&quot;

The Impact of DENV-1 Genotypes on the Immune Response of Natural Homotypic Infections.

Development of an RT-LAMP Assay for the Rapid Detection of SFTS Virus.

Yuki Takamatsu has been accepted by the "Takeda Science Foundation Medical Research Grant"